IMS Health Holdings, Inc. IMS
Set alert
31.34 0.00 0.00%
At close · Jun 28
30.37 Day range 31.34
22.36 52-week range 31.59
- Open
- 30.50
- Prev close
- 31.34
- Mkt cap
- 0
- Vol
- 4.03M
- Avg vol
- 1.26M
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 30.37
- High
- 31.34
- Earnings
- Nov 3, 2016
Next earnings
Nov 3, 2016
Expected Nov 3, 2016. Consensus EPS estimate 0.36.
Financials — quick view
IMS Revenue — quarterly 802.00M
IMS Net income — quarterly 24.00M
IMS EPS — quarterly 0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2016 | Sep 1, 2016 | 0.36 | — | — | — |
| Jul 27, 2016 | Jun 1, 2016 | 0.38 | — | — | — |
| May 3, 2016 | Mar 1, 2016 | 0.38 | — | — | — |
| Feb 3, 2016 | Dec 1, 2015 | 0.32 | — | — | — |
| Oct 29, 2015 | Sep 1, 2015 | 0.33 | — | — | — |
| Jul 31, 2015 | Jun 1, 2015 | 0.30 | — | — | — |
News
- C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting
- AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting
- C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
- MACOM and Elve to Demonstrate a V-Band Linearized TWTA for Satellite Communications and Defense Applications at IMS 2026
- Guerrilla RF Announces Expanded Focus on Tactical Radio Market, Debuts New Solutions Guide at IMS2026
- MACOM IMS 2026 Product Announcements for Satellite Communications
- MACOM IMS 2026 Product Announcements for Aerospace and Defense
- Aramark Sports + Entertainment Drives New Food & Beverage and Premium Hospitality Experiences at Indianapolis Motor Speedway for 2026
- IMS Announces Executive AEO Training to Help Companies Increase Visibility Across Generative AI Platforms Including ChatGPT, Claude, Grok, and Perplexity
- Charles River Wealth to Expand Capabilities Supporting Private Assets within Unified Managed Accounts (UMA)
Your note
Sign in to keep a note on IMS — it syncs with the Stock Master app.